Adenocarcinoma In Situ — Trials

Adenocarcinoma In Situ — Trials · CancerIndex

Clinical trials

Registered studies

210 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 61
Recruiting: 31
Ph III recruiting: 3
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04248179	The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.	completed	Phase 4	36	Zealand University HospitalOTHER	1	Feb 9, 2023	clinicaltrials
NCT01544478	V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)	completed	Phase 4	1,030	Merck Sharp & Dohme LLCINDUSTRY	0	Nov 28, 2018	clinicaltrials